Skip to content
10-K

Annual Report

OSIRIS THERAPEUTICS, INC.

0001558370-19-002094

← back to feed
Filed
Mar 15, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Mar 1, 2019 34.53M sh
Shares Diluted FY 2018 · Dec 31, 2018 34.57M sh
Shares Diluted FY 2018 · Dec 31, 2017 34.53M sh
Capex FY 2018 · Dec 31, 2018 $242K
Capex FY 2018 · Dec 31, 2017 $2.01M
Operating Cash Flow FY 2018 · Dec 31, 2018 $7.3M
Operating Cash Flow FY 2018 · Dec 31, 2017 −$5.22M
Cash And Equivalents FY 2018 · Dec 31, 2018 $16.37M
Cash And Equivalents FY 2018 · Dec 31, 2017 $3.08M
Stockholders Equity FY 2018 · Dec 31, 2018 $78.53M
Stockholders Equity FY 2018 · Dec 31, 2017 $41.39M
Stockholders Equity FY 2018 · Dec 31, 2016 $32.5M
Current Liabilities FY 2018 · Dec 31, 2018 $20.59M
Current Liabilities FY 2018 · Dec 31, 2017 $35.1M
Total Liabilities FY 2018 · Dec 31, 2018 $22.97M
Total Liabilities FY 2018 · Dec 31, 2017 $36.73M
Current Assets FY 2018 · Dec 31, 2018 $70.25M
Current Assets FY 2018 · Dec 31, 2017 $72.93M
Total Assets FY 2018 · Dec 31, 2018 $101.5M
Total Assets FY 2018 · Dec 31, 2017 $78.12M
Eps Diluted FY 2018 · Dec 31, 2018 $1.07
Eps Diluted FY 2018 · Dec 31, 2017 $0.25
Eps Basic FY 2018 · Dec 31, 2018 $1.07
Eps Basic FY 2018 · Dec 31, 2017 $0.25
Rd Expense FY 2018 · Dec 31, 2018 $6.76M
Rd Expense FY 2018 · Dec 31, 2017 $4.14M
Net Income FY 2018 · Dec 31, 2018 $36.9M
Net Income FY 2018 · Dec 31, 2017 $8.79M
Operating Income FY 2018 · Dec 31, 2018 $9.85M
Operating Income FY 2018 · Dec 31, 2017 −$1.99M
Gross Profit FY 2018 · Dec 31, 2018 $104.69M
Gross Profit FY 2018 · Dec 31, 2017 $85.83M
Revenue FY 2018 · Dec 31, 2018 $142.82M
Revenue FY 2018 · Dec 31, 2017 $118.51M